The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Yocum Richard C since year 2005.
The trader's CIK number is 1323495.
At the time of this reporting, Yocum Richard C is the VP Clinical Developm of Halozyme Therapeutics Inc .
(stock ticker symbol HTI).
See this page for all insider trading activities at Halozyme Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2007-03-22||HTI||Halozyme Therapeutics Inc||Sale||29,858||8.51||254,091|
|2007-03-21||HTI||Halozyme Therapeutics Inc||Option Ex||95,833||1.87||179,207|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yocum Richard C (VP Clinical Developm of Halozyme Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.